PMC:7394275 / 21662-21893
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T323 | 213-221 | SP_7 | denotes | COVID-19 |
| T99766 | 213-221 | SP_7 | denotes | COVID-19 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 642 | 222-230 | Species | denotes | patients | Tax:9606 |
| 658 | 66-82 | Disease | denotes | invasive mycosis | MESH:D015821 |
| 659 | 213-221 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T199 | 75-82 | Disease | denotes | mycosis | http://purl.obolibrary.org/obo/MONDO_0002041 |
| T200 | 213-221 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T109 | 0-231 | Sentence | denotes | We suggest it is prudent to assess the risk factors, the types of invasive mycosis, the strengths and limitations of diagnostic methods, clinical settings, and the need for standard or individualized treatment in COVID-19 patients. |